Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral alkalizers in chronic kidney disease
jRCTs021180043Completed
- Sponsor
- Nippon Chemiphar
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sodium citrate + potassium citrate in chronic kidney disease (CKD) (3 arms), sponsored by Nippon Chemiphar. Primary endpoints: Serum creatinine level, Estimated glomerular filtration rate and 2 more. Started Apr 2013; status: completed.
02
Drugs
sodium citrate + potassium citrate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCTs021180043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180043.